Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol/Fluticasone Eurofarma vs Foraseq vs Fluticasone in Persistent Asthma
NCT01202084Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Jan 2012
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of formoterol, fluticasone propionate in asthma, sponsored by Eurofarma. Started Jan 2012; status: completed.
02
Drugs
formoterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01202084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01202084.